share_log

国金证券4月25日发布研报称，给予美年健康（002044.SZ）买入评级。评级理由主要包括：1）四大品牌协同发展，量价齐升促业绩增长；2）数字化运营赋能发展，布局AI持续创新。（每日经济新闻）

Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to p

Zhitong Finance ·  Apr 25 10:50
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to promote performance growth; 2) digital operation enables development, and the layout of AI continues to innovate. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment